Kerry R. Hicks's Insider Trades & SAST Disclosures

Kerry R. Hicks's most recent trade in TriSalus Life Sciences Inc was a trade of 15,000 Director stock option (right to buy) done . Disclosure was reported to the exchange on Aug. 13, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
TriSalus Life Sciences Inc
Kerry R. Hicks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2024 15,000 15,000 - - Director stock option (right to buy)
TriSalus Life Sciences Inc
Kerry R. Hicks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Aug 2023 35,000 35,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades